-
1
-
-
0033051101
-
Direct analysis of protein complexes using mass spectrometry
-
Link, A. J.; Eng, J.; Schieltz, D. M.; Carmack, E.; Mize, G. J.; Morris, D. R.; Garvik, B. M.; Yates, J. R., 3rd Direct analysis of protein complexes using mass spectrometry Nat. Biotechnol. 1999, 17, 676-682
-
(1999)
Nat. Biotechnol.
, vol.17
, pp. 676-682
-
-
Link, A.J.1
Eng, J.2
Schieltz, D.M.3
Carmack, E.4
Mize, G.J.5
Morris, D.R.6
Garvik, B.M.7
Yates III, J.R.8
-
2
-
-
0031962612
-
Mass spectrometry and the age of the proteome
-
Yates, J. R., 3rd Mass spectrometry and the age of the proteome J. Mass Spectrom. 1998, 33, 1-19
-
(1998)
J. Mass Spectrom.
, vol.33
, pp. 1-19
-
-
Yates III, J.R.1
-
3
-
-
0036171359
-
De novo peptide sequencing and quantitative profiling of complex protein mixtures using mass-coded abundance tagging
-
Cagney, G.; Emili, A. De novo peptide sequencing and quantitative profiling of complex protein mixtures using mass-coded abundance tagging Nat. Biotechnol. 2002, 20, 163-170
-
(2002)
Nat. Biotechnol.
, vol.20
, pp. 163-170
-
-
Cagney, G.1
Emili, A.2
-
4
-
-
0032875697
-
Quantitative analysis of complex protein mixtures using isotope-coded affinity tags
-
Gygi, S. P.; Rist, B.; Gerber, S. A.; Turecek, F.; Gelb, M. H.; Aebersold, R. Quantitative analysis of complex protein mixtures using isotope-coded affinity tags Nat. Biotechnol. 1999, 17, 994-999
-
(1999)
Nat. Biotechnol.
, vol.17
, pp. 994-999
-
-
Gygi, S.P.1
Rist, B.2
Gerber, S.A.3
Turecek, F.4
Gelb, M.H.5
Aebersold, R.6
-
5
-
-
0036583926
-
Stable isotope labeling by amino acids in cell culture, SILAC, as a simple and accurate approach to expression proteomics
-
Ong, S. E.; Blagoev, B.; Kratchmarova, I.; Kristensen, D. B.; Steen, H.; Pandey, A.; Mann, M. Stable isotope labeling by amino acids in cell culture, SILAC, as a simple and accurate approach to expression proteomics Mol. Cell. Proteomics 2002, 1, 376-386
-
(2002)
Mol. Cell. Proteomics
, vol.1
, pp. 376-386
-
-
Ong, S.E.1
Blagoev, B.2
Kratchmarova, I.3
Kristensen, D.B.4
Steen, H.5
Pandey, A.6
Mann, M.7
-
6
-
-
0037304325
-
Quantitative proteomics using mass spectrometry
-
Sechi, S.; Oda, Y. Quantitative proteomics using mass spectrometry Curr. Opin. Chem. Biol. 2003, 7, 70-77
-
(2003)
Curr. Opin. Chem. Biol.
, vol.7
, pp. 70-77
-
-
Sechi, S.1
Oda, Y.2
-
7
-
-
27644537898
-
The roles of multiple proteomic platforms in a pipeline for new diagnostics
-
Anderson, N. L. The roles of multiple proteomic platforms in a pipeline for new diagnostics Mol. Cell. Proteomics 2005, 4, 1441-1444
-
(2005)
Mol. Cell. Proteomics
, vol.4
, pp. 1441-1444
-
-
Anderson, N.L.1
-
8
-
-
33745560074
-
The US Food and Drug Administration perspective on cancer biomarker development
-
Gutman, S.; Kessler, L. G. The US Food and Drug Administration perspective on cancer biomarker development Nat. Rev. Cancer 2006, 6, 565-571
-
(2006)
Nat. Rev. Cancer
, vol.6
, pp. 565-571
-
-
Gutman, S.1
Kessler, L.G.2
-
9
-
-
33747030845
-
Protein biomarker discovery and validation: The long and uncertain path to clinical utility
-
Rifai, N.; Gillette, M. A.; Carr, S. A. Protein biomarker discovery and validation: the long and uncertain path to clinical utility Nat. Biotechnol. 2006, 24, 971-983
-
(2006)
Nat. Biotechnol.
, vol.24
, pp. 971-983
-
-
Rifai, N.1
Gillette, M.A.2
Carr, S.A.3
-
10
-
-
0037649064
-
Liquid chromatography/atmospheric pressure ionization-mass spectrometry in drug metabolism studies
-
Kostiainen, R.; Kotiaho, T.; Kuuranne, T.; Auriola, S. Liquid chromatography/atmospheric pressure ionization-mass spectrometry in drug metabolism studies J. Mass Spectrom. 2003, 38, 357-372
-
(2003)
J. Mass Spectrom.
, vol.38
, pp. 357-372
-
-
Kostiainen, R.1
Kotiaho, T.2
Kuuranne, T.3
Auriola, S.4
-
11
-
-
4444276389
-
Development and evaluation of a reference measurement procedure for the determination of total 3,3′,5-triiodothyronine in human serum using isotope-dilution liquid chromatography-tandem mass spectrometry
-
Tai, S. S.; Bunk, D. M.; White, E.t.; Welch, M. J. Development and evaluation of a reference measurement procedure for the determination of total 3,3′,5-triiodothyronine in human serum using isotope-dilution liquid chromatography-tandem mass spectrometry Anal. Chem. 2004, 76, 5092-5096
-
(2004)
Anal. Chem.
, vol.76
, pp. 5092-5096
-
-
Tai, S.S.1
Bunk, D.M.2
White, E.T.3
Welch, M.J.4
-
12
-
-
33645721632
-
Quantitative mass spectrometric multiple reaction monitoring assays for major plasma proteins
-
Anderson, L.; Hunter, C. L. Quantitative mass spectrometric multiple reaction monitoring assays for major plasma proteins Mol. Cell. Proteomics 2006, 5, 573-588
-
(2006)
Mol. Cell. Proteomics
, vol.5
, pp. 573-588
-
-
Anderson, L.1
Hunter, C.L.2
-
13
-
-
84862832755
-
Multiplexed quantification of 63 proteins in human urine by multiple reaction monitoring-based mass spectrometry for discovery of potential bladder cancer biomarkers
-
Chen, Y. T.; Chen, H. W.; Domanski, D.; Smith, D. S.; Liang, K. H.; Wu, C. C.; Chen, C. L.; Chung, T.; Chen, M. C.; Chang, Y. S.; Parker, C. E.; Borchers, C. H.; Yu, J. S. Multiplexed quantification of 63 proteins in human urine by multiple reaction monitoring-based mass spectrometry for discovery of potential bladder cancer biomarkers J. Proteomics 2012, 75, 3529-3545
-
(2012)
J. Proteomics
, vol.75
, pp. 3529-3545
-
-
Chen, Y.T.1
Chen, H.W.2
Domanski, D.3
Smith, D.S.4
Liang, K.H.5
Wu, C.C.6
Chen, C.L.7
Chung, T.8
Chen, M.C.9
Chang, Y.S.10
Parker, C.E.11
Borchers, C.H.12
Yu, J.S.13
-
14
-
-
38349068918
-
Quantitative, multiplexed assays for low abundance proteins in plasma by targeted mass spectrometry and stable isotope dilution
-
Keshishian, H.; Addona, T.; Burgess, M.; Kuhn, E.; Carr, S. A. Quantitative, multiplexed assays for low abundance proteins in plasma by targeted mass spectrometry and stable isotope dilution Mol. Cell. Proteomics 2007, 6, 2212-2229
-
(2007)
Mol. Cell. Proteomics
, vol.6
, pp. 2212-2229
-
-
Keshishian, H.1
Addona, T.2
Burgess, M.3
Kuhn, E.4
Carr, S.A.5
-
15
-
-
55049104915
-
Accurate inclusion mass screening: A bridge from unbiased discovery to targeted assay development for biomarker verification
-
Jaffe, J. D.; Keshishian, H.; Chang, B.; Addona, T. A.; Gillette, M. A.; Carr, S. A. Accurate inclusion mass screening: a bridge from unbiased discovery to targeted assay development for biomarker verification Mol. Cell. Proteomics 2008, 7, 1952-1962
-
(2008)
Mol. Cell. Proteomics
, vol.7
, pp. 1952-1962
-
-
Jaffe, J.D.1
Keshishian, H.2
Chang, B.3
Addona, T.A.4
Gillette, M.A.5
Carr, S.A.6
-
16
-
-
33644876912
-
The PeptideAtlas project
-
Desiere, F.; Deutsch, E. W.; King, N. L.; Nesvizhskii, A. I.; Mallick, P.; Eng, J.; Chen, S.; Eddes, J.; Loevenich, S. N.; Aebersold, R. The PeptideAtlas project Nucleic Acids Res. 2006, 34, D655-658
-
(2006)
Nucleic Acids Res.
, vol.34
, pp. 655-658
-
-
Desiere, F.1
Deutsch, E.W.2
King, N.L.3
Nesvizhskii, A.I.4
Mallick, P.5
Eng, J.6
Chen, S.7
Eddes, J.8
Loevenich, S.N.9
Aebersold, R.10
-
17
-
-
77449108855
-
The PeptideAtlas Project
-
Deutsch, E. W. The PeptideAtlas Project Methods Mol. Biol. 2010, 604, 285-296
-
(2010)
Methods Mol. Biol.
, vol.604
, pp. 285-296
-
-
Deutsch, E.W.1
-
18
-
-
55349095003
-
Protein quantitation through targeted mass spectrometry: The way out of biomarker purgatory?
-
Carr, S. A.; Anderson, L. Protein quantitation through targeted mass spectrometry: the way out of biomarker purgatory? Clin. Chem. 2008, 54, 1749-1752
-
(2008)
Clin. Chem.
, vol.54
, pp. 1749-1752
-
-
Carr, S.A.1
Anderson, L.2
-
19
-
-
79960214321
-
A targeted proteomics-based pipeline for verification of biomarkers in plasma
-
Whiteaker, J. R.; Lin, C.; Kennedy, J.; Hou, L.; Trute, M.; Sokal, I.; Yan, P.; Schoenherr, R. M.; Zhao, L.; Voytovich, U. J.; Kelly-Spratt, K. S.; Krasnoselsky, A.; Gafken, P. R.; Hogan, J. M.; Jones, L. A.; Wang, P.; Amon, L.; Chodosh, L. A.; Nelson, P. S.; McIntosh, M. W.; Kemp, C. J.; Paulovich, A. G. A targeted proteomics-based pipeline for verification of biomarkers in plasma Nat. Biotechnol. 2011, 29, 625-634
-
(2011)
Nat. Biotechnol.
, vol.29
, pp. 625-634
-
-
Whiteaker, J.R.1
Lin, C.2
Kennedy, J.3
Hou, L.4
Trute, M.5
Sokal, I.6
Yan, P.7
Schoenherr, R.M.8
Zhao, L.9
Voytovich, U.J.10
Kelly-Spratt, K.S.11
Krasnoselsky, A.12
Gafken, P.R.13
Hogan, J.M.14
Jones, L.A.15
Wang, P.16
Amon, L.17
Chodosh, L.A.18
Nelson, P.S.19
McIntosh, M.W.20
Kemp, C.J.21
Paulovich, A.G.22
more..
-
20
-
-
84863923380
-
Reproducible quantification of cancer-associated proteins in body fluids using targeted proteomics
-
Huttenhain, R.; Soste, M.; Selevsek, N.; Rost, H.; Sethi, A.; Carapito, C.; Farrah, T.; Deutsch, E. W.; Kusebauch, U.; Moritz, R. L.; Nimeus-Malmstrom, E.; Rinner, O.; Aebersold, R. Reproducible quantification of cancer-associated proteins in body fluids using targeted proteomics Sci. Transl. Med. 2012, 4, 142ra194
-
(2012)
Sci. Transl. Med.
, vol.4
-
-
Huttenhain, R.1
Soste, M.2
Selevsek, N.3
Rost, H.4
Sethi, A.5
Carapito, C.6
Farrah, T.7
Deutsch, E.W.8
Kusebauch, U.9
Moritz, R.L.10
Nimeus-Malmstrom, E.11
Rinner, O.12
Aebersold, R.13
-
21
-
-
79960269601
-
A pipeline that integrates the discovery and verification of plasma protein biomarkers reveals candidate markers for cardiovascular disease
-
Addona, T. A.; Shi, X.; Keshishian, H.; Mani, D. R.; Burgess, M.; Gillette, M. A.; Clauser, K. R.; Shen, D.; Lewis, G. D.; Farrell, L. A.; Fifer, M. A.; Sabatine, M. S.; Gerszten, R. E.; Carr, S. A. A pipeline that integrates the discovery and verification of plasma protein biomarkers reveals candidate markers for cardiovascular disease Nat. Biotechnol. 2011, 29, 635-643
-
(2011)
Nat. Biotechnol.
, vol.29
, pp. 635-643
-
-
Addona, T.A.1
Shi, X.2
Keshishian, H.3
Mani, D.R.4
Burgess, M.5
Gillette, M.A.6
Clauser, K.R.7
Shen, D.8
Lewis, G.D.9
Farrell, L.A.10
Fifer, M.A.11
Sabatine, M.S.12
Gerszten, R.E.13
Carr, S.A.14
-
22
-
-
0037141853
-
Clinical practice. Pleural effusion
-
Light, R. W. Clinical practice. Pleural effusion N. Engl. J. Med. 2002, 346, 1971-1977
-
(2002)
N. Engl. J. Med.
, vol.346
, pp. 1971-1977
-
-
Light, R.W.1
-
23
-
-
33645544932
-
Diagnostic approach to pleural effusion in adults
-
Porcel, J. M.; Light, R. W. Diagnostic approach to pleural effusion in adults Am. Fam. Physician 2006, 73, 1211-1220
-
(2006)
Am. Fam. Physician
, vol.73
, pp. 1211-1220
-
-
Porcel, J.M.1
Light, R.W.2
-
24
-
-
0018242739
-
The significance of a cytologically negative pleural effusion in bronchogenic carcinoma
-
Decker, D. A.; Dines, D. E.; Payne, W. S.; Bernatz, P. E.; Pairolero, P. C. The significance of a cytologically negative pleural effusion in bronchogenic carcinoma Chest 1978, 74, 640-642
-
(1978)
Chest
, vol.74
, pp. 640-642
-
-
Decker, D.A.1
Dines, D.E.2
Payne, W.S.3
Bernatz, P.E.4
Pairolero, P.C.5
-
25
-
-
0021926462
-
The malignant pleural effusion. A review of cytopathologic diagnoses of 584 specimens from 472 consecutive patients
-
Johnston, W. W. The malignant pleural effusion. A review of cytopathologic diagnoses of 584 specimens from 472 consecutive patients Cancer 1985, 56, 905-909
-
(1985)
Cancer
, vol.56
, pp. 905-909
-
-
Johnston, W.W.1
-
26
-
-
39749099436
-
Recent advances in the diagnosis and management of malignant pleural effusions
-
Heffner, J. E.; Klein, J. S. Recent advances in the diagnosis and management of malignant pleural effusions Mayo Clin. Proc. 2008, 83, 235-250
-
(2008)
Mayo Clin. Proc.
, vol.83
, pp. 235-250
-
-
Heffner, J.E.1
Klein, J.S.2
-
27
-
-
0030816496
-
Pleural diseases related to metastatic malignancies
-
Sahn, S. A. Pleural diseases related to metastatic malignancies Eur. Respir. J. 1997, 10, 1907-1913
-
(1997)
Eur. Respir. J.
, vol.10
, pp. 1907-1913
-
-
Sahn, S.A.1
-
28
-
-
0037688044
-
BTS guidelines for the investigation of a unilateral pleural effusion in adults
-
Maskell, N. A.; Butland, R. J. BTS guidelines for the investigation of a unilateral pleural effusion in adults Thorax 2003, 58, ii8-17
-
(2003)
Thorax
, vol.58
, pp. 8-17
-
-
Maskell, N.A.1
Butland, R.J.2
-
29
-
-
58149193222
-
Human protein reference database-2009 update
-
Keshava Prasad, T. S.; Goel, R.; Kandasamy, K.; Keerthikumar, S.; Kumar, S.; Mathivanan, S.; Telikicherla, D.; Raju, R.; Shafreen, B.; Venugopal, A.; Balakrishnan, L.; Marimuthu, A.; Banerjee, S.; Somanathan, D. S.; Sebastian, A.; Rani, S.; Ray, S.; Harrys Kishore, C. J.; Kanth, S.; Ahmed, M.; Kashyap, M. K.; Mohmood, R.; Ramachandra, Y. L.; Krishna, V.; Rahiman, B. A.; Mohan, S.; Ranganathan, P.; Ramabadran, S.; Chaerkady, R.; Pandey, A. Human protein reference database-2009 update Nucleic Acids Res. 2009, 37, D767-D772
-
(2009)
Nucleic Acids Res.
, vol.37
-
-
Keshava Prasad, T.S.1
Goel, R.2
Kandasamy, K.3
Keerthikumar, S.4
Kumar, S.5
Mathivanan, S.6
Telikicherla, D.7
Raju, R.8
Shafreen, B.9
Venugopal, A.10
Balakrishnan, L.11
Marimuthu, A.12
Banerjee, S.13
Somanathan, D.S.14
Sebastian, A.15
Rani, S.16
Ray, S.17
Harrys Kishore, C.J.18
Kanth, S.19
Ahmed, M.20
Kashyap, M.K.21
Mohmood, R.22
Ramachandra, Y.L.23
Krishna, V.24
Rahiman, B.A.25
Mohan, S.26
Ranganathan, P.27
Ramabadran, S.28
Chaerkady, R.29
Pandey, A.30
more..
-
30
-
-
23144442824
-
Multiplexed absolute quantification in proteomics using artificial QCAT proteins of concatenated signature peptides
-
Beynon, R. J.; Doherty, M. K.; Pratt, J. M.; Gaskell, S. J. Multiplexed absolute quantification in proteomics using artificial QCAT proteins of concatenated signature peptides Nat. Methods 2005, 2, 587-589
-
(2005)
Nat. Methods
, vol.2
, pp. 587-589
-
-
Beynon, R.J.1
Doherty, M.K.2
Pratt, J.M.3
Gaskell, S.J.4
-
31
-
-
34548427053
-
Absolute multiplexed quantitative analysis of protein expression during muscle development using QconCAT
-
Rivers, J.; Simpson, D. M.; Robertson, D. H.; Gaskell, S. J.; Beynon, R. J. Absolute multiplexed quantitative analysis of protein expression during muscle development using QconCAT Mol. Cell. Proteomics 2007, 6, 1416-1427
-
(2007)
Mol. Cell. Proteomics
, vol.6
, pp. 1416-1427
-
-
Rivers, J.1
Simpson, D.M.2
Robertson, D.H.3
Gaskell, S.J.4
Beynon, R.J.5
-
33
-
-
34548409217
-
Experimental and statistical considerations to avoid false conclusions in proteomics studies using differential in-gel electrophoresis
-
Karp, N. A.; McCormick, P. S.; Russell, M. R.; Lilley, K. S. Experimental and statistical considerations to avoid false conclusions in proteomics studies using differential in-gel electrophoresis Mol. Cell. Proteomics 2007, 6, 1354-1364
-
(2007)
Mol. Cell. Proteomics
, vol.6
, pp. 1354-1364
-
-
Karp, N.A.1
McCormick, P.S.2
Russell, M.R.3
Lilley, K.S.4
-
34
-
-
84655167699
-
Use of discard pleural fluid in molecular research
-
Grannis, F. W., Jr. Use of discard pleural fluid in molecular research Nat. Rev. Clin. Oncol. 2012, 9, 64
-
(2012)
Nat. Rev. Clin. Oncol.
, vol.9
, pp. 64
-
-
Grannis, Jr.F.W.1
-
35
-
-
80053569318
-
The ethical use of mandatory research biopsies
-
Olson, E. M.; Lin, N. U.; Krop, I. E.; Winer, E. P. The ethical use of mandatory research biopsies Nat. Rev. Clin. Oncol. 2011, 8, 620-625
-
(2011)
Nat. Rev. Clin. Oncol.
, vol.8
, pp. 620-625
-
-
Olson, E.M.1
Lin, N.U.2
Krop, I.E.3
Winer, E.P.4
-
36
-
-
0035854741
-
Molecular basis for the homophilic activated leukocyte cell adhesion molecule (ALCAM)-ALCAM interaction
-
van Kempen, L. C.; Nelissen, J. M.; Degen, W. G.; Torensma, R.; Weidle, U. H.; Bloemers, H. P.; Figdor, C. G.; Swart, G. W. Molecular basis for the homophilic activated leukocyte cell adhesion molecule (ALCAM)-ALCAM interaction J. Biol. Chem. 2001, 276, 25783-25790
-
(2001)
J. Biol. Chem.
, vol.276
, pp. 25783-25790
-
-
Van Kempen, L.C.1
Nelissen, J.M.2
Degen, W.G.3
Torensma, R.4
Weidle, U.H.5
Bloemers, H.P.6
Figdor, C.G.7
Swart, G.W.8
-
37
-
-
78650635846
-
Clinical implication of CD166 expression in gastric cancer
-
Ishigami, S.; Ueno, S.; Arigami, T.; Arima, H.; Uchikado, Y.; Kita, Y.; Sasaki, K.; Nishizono, Y.; Omoto, I.; Kurahara, H.; Matsumoto, M.; Kijima, Y.; Natsugoe, S. Clinical implication of CD166 expression in gastric cancer J. Surg. Oncol. 2011, 103, 57-61
-
(2011)
J. Surg. Oncol.
, vol.103
, pp. 57-61
-
-
Ishigami, S.1
Ueno, S.2
Arigami, T.3
Arima, H.4
Uchikado, Y.5
Kita, Y.6
Sasaki, K.7
Nishizono, Y.8
Omoto, I.9
Kurahara, H.10
Matsumoto, M.11
Kijima, Y.12
Natsugoe, S.13
-
38
-
-
84870712387
-
Membranous expression of activated leukocyte cell adhesion molecule contributes to poor prognosis and malignant phenotypes of non-small-cell lung cancer
-
Ishiguro, F.; Murakami, H.; Mizuno, T.; Fujii, M.; Kondo, Y.; Usami, N.; Taniguchi, T.; Yokoi, K.; Osada, H.; Sekido, Y. Membranous expression of activated leukocyte cell adhesion molecule contributes to poor prognosis and malignant phenotypes of non-small-cell lung cancer J. Surg. Res. 2013, 179, 24-32
-
(2013)
J. Surg. Res.
, vol.179
, pp. 24-32
-
-
Ishiguro, F.1
Murakami, H.2
Mizuno, T.3
Fujii, M.4
Kondo, Y.5
Usami, N.6
Taniguchi, T.7
Yokoi, K.8
Osada, H.9
Sekido, Y.10
-
39
-
-
37849052165
-
Subcellular localization of activated leukocyte cell adhesion molecule is a molecular predictor of survival in ovarian carcinoma patients
-
Mezzanzanica, D.; Fabbi, M.; Bagnoli, M.; Staurengo, S.; Losa, M.; Balladore, E.; Alberti, P.; Lusa, L.; Ditto, A.; Ferrini, S.; Pierotti, M. A.; Barbareschi, M.; Pilotti, S.; Canevari, S. Subcellular localization of activated leukocyte cell adhesion molecule is a molecular predictor of survival in ovarian carcinoma patients Clin. Cancer Res. 2008, 14, 1726-1733
-
(2008)
Clin. Cancer Res.
, vol.14
, pp. 1726-1733
-
-
Mezzanzanica, D.1
Fabbi, M.2
Bagnoli, M.3
Staurengo, S.4
Losa, M.5
Balladore, E.6
Alberti, P.7
Lusa, L.8
Ditto, A.9
Ferrini, S.10
Pierotti, M.A.11
Barbareschi, M.12
Pilotti, S.13
Canevari, S.14
-
40
-
-
84865066555
-
Activated leukocyte cell adhesion molecule (CD166)-its prognostic power for colorectal cancer patients
-
Tachezy, M.; Zander, H.; Gebauer, F.; Marx, A.; Kaifi, J. T.; Izbicki, J. R.; Bockhorn, M. Activated leukocyte cell adhesion molecule (CD166)-its prognostic power for colorectal cancer patients J. Surg. Res. 2012, 177, e15-20
-
(2012)
J. Surg. Res.
, vol.177
, pp. 15-20
-
-
Tachezy, M.1
Zander, H.2
Gebauer, F.3
Marx, A.4
Kaifi, J.T.5
Izbicki, J.R.6
Bockhorn, M.7
-
41
-
-
84892369037
-
Targets in small cell lung cancer
-
Teicher, B. A. Targets in small cell lung cancer Biochem. Pharmacol. 2014, 87, 211-219
-
(2014)
Biochem. Pharmacol.
, vol.87
, pp. 211-219
-
-
Teicher, B.A.1
-
42
-
-
84860548060
-
Detection of activated leukocyte cell adhesion molecule in the serum of breast cancer patients and implications for prognosis
-
Witzel, I.; Schroder, C.; Muller, V.; Zander, H.; Tachezy, M.; Ihnen, M.; Janicke, F.; Milde-Langosch, K. Detection of activated leukocyte cell adhesion molecule in the serum of breast cancer patients and implications for prognosis Oncology 2012, 82, 305-312
-
(2012)
Oncology
, vol.82
, pp. 305-312
-
-
Witzel, I.1
Schroder, C.2
Muller, V.3
Zander, H.4
Tachezy, M.5
Ihnen, M.6
Janicke, F.7
Milde-Langosch, K.8
-
43
-
-
84877863177
-
Elevated ALCAM shedding in colorectal cancer correlates with poor patient outcome
-
Hansen, A. G.; Freeman, T. J.; Arnold, S. A.; Starchenko, A.; Jones-Paris, C. R.; Gilger, M. A.; Washington, M. K.; Fan, K. H.; Shyr, Y.; Beauchamp, R. D.; Zijlstra, A. Elevated ALCAM shedding in colorectal cancer correlates with poor patient outcome Cancer Res. 2013, 73, 2955-2964
-
(2013)
Cancer Res.
, vol.73
, pp. 2955-2964
-
-
Hansen, A.G.1
Freeman, T.J.2
Arnold, S.A.3
Starchenko, A.4
Jones-Paris, C.R.5
Gilger, M.A.6
Washington, M.K.7
Fan, K.H.8
Shyr, Y.9
Beauchamp, R.D.10
Zijlstra, A.11
-
44
-
-
84866631390
-
Prognostic impact of malignant pleural effusion at presentation in patients with metastatic non-small-cell lung cancer
-
Morgensztern, D.; Waqar, S.; Subramanian, J.; Trinkaus, K.; Govindan, R. Prognostic impact of malignant pleural effusion at presentation in patients with metastatic non-small-cell lung cancer J. Thorac. Oncol. 2012, 7, 1485-1489
-
(2012)
J. Thorac. Oncol.
, vol.7
, pp. 1485-1489
-
-
Morgensztern, D.1
Waqar, S.2
Subramanian, J.3
Trinkaus, K.4
Govindan, R.5
-
45
-
-
0017758251
-
Functional correlation between cell adhesive properties and some cell surface proteins
-
Takeichi, M. Functional correlation between cell adhesive properties and some cell surface proteins J. Cell Biol. 1977, 75, 464-474
-
(1977)
J. Cell Biol.
, vol.75
, pp. 464-474
-
-
Takeichi, M.1
-
46
-
-
0023926935
-
The cadherins: Cell-cell adhesion molecules controlling animal morphogenesis
-
Takeichi, M. The cadherins: cell-cell adhesion molecules controlling animal morphogenesis Development 1988, 102, 639-655
-
(1988)
Development
, vol.102
, pp. 639-655
-
-
Takeichi, M.1
-
47
-
-
0025818032
-
Genetic manipulation of E-cadherin expression by epithelial tumor cells reveals an invasion suppressor role
-
Vleminckx, K.; Vakaet, L., Jr.; Mareel, M.; Fiers, W.; van Roy, F. Genetic manipulation of E-cadherin expression by epithelial tumor cells reveals an invasion suppressor role Cell 1991, 66, 107-119
-
(1991)
Cell
, vol.66
, pp. 107-119
-
-
Vleminckx, K.1
Vakaet, Jr.L.2
Mareel, M.3
Fiers, W.4
Van Roy, F.5
-
48
-
-
21544467772
-
ADAM10 mediates E-cadherin shedding and regulates epithelial cell-cell adhesion, migration, and beta-catenin translocation
-
Maretzky, T.; Reiss, K.; Ludwig, A.; Buchholz, J.; Scholz, F.; Proksch, E.; de Strooper, B.; Hartmann, D.; Saftig, P. ADAM10 mediates E-cadherin shedding and regulates epithelial cell-cell adhesion, migration, and beta-catenin translocation Proc. Natl. Acad. Sci. U.S.A. 2005, 102, 9182-9187
-
(2005)
Proc. Natl. Acad. Sci. U.S.A.
, vol.102
, pp. 9182-9187
-
-
Maretzky, T.1
Reiss, K.2
Ludwig, A.3
Buchholz, J.4
Scholz, F.5
Proksch, E.6
De Strooper, B.7
Hartmann, D.8
Saftig, P.9
-
49
-
-
0035147313
-
Release of an invasion promoter E-cadherin fragment by matrilysin and stromelysin-1
-
Noe, V.; Fingleton, B.; Jacobs, K.; Crawford, H. C.; Vermeulen, S.; Steelant, W.; Bruyneel, E.; Matrisian, L. M.; Mareel, M. Release of an invasion promoter E-cadherin fragment by matrilysin and stromelysin-1 J. Cell Sci. 2001, 114, 111-118
-
(2001)
J. Cell Sci.
, vol.114
, pp. 111-118
-
-
Noe, V.1
Fingleton, B.2
Jacobs, K.3
Crawford, H.C.4
Vermeulen, S.5
Steelant, W.6
Bruyneel, E.7
Matrisian, L.M.8
Mareel, M.9
-
50
-
-
79551505279
-
Soluble E-cadherin as a serum biomarker candidate: Elevated levels in patients with late-stage colorectal carcinoma and FAP
-
Weiss, J. V.; Klein-Scory, S.; Kubler, S.; Reinacher-Schick, A.; Stricker, I.; Schmiegel, W.; Schwarte-Waldhoff, I. Soluble E-cadherin as a serum biomarker candidate: elevated levels in patients with late-stage colorectal carcinoma and FAP Int. J. Cancer 2011, 128, 1384-1392
-
(2011)
Int. J. Cancer
, vol.128
, pp. 1384-1392
-
-
Weiss, J.V.1
Klein-Scory, S.2
Kubler, S.3
Reinacher-Schick, A.4
Stricker, I.5
Schmiegel, W.6
Schwarte-Waldhoff, I.7
-
51
-
-
0037479789
-
Mucin and Toll-like receptors in host defense against intestinal parasites
-
Moncada, D. M.; Kammanadiminti, S. J.; Chadee, K. Mucin and Toll-like receptors in host defense against intestinal parasites Trends Parasitol. 2003, 19, 305-311
-
(2003)
Trends Parasitol.
, vol.19
, pp. 305-311
-
-
Moncada, D.M.1
Kammanadiminti, S.J.2
Chadee, K.3
-
52
-
-
0021740104
-
Differential reactivity of a novel monoclonal antibody (DF3) with human malignant versus benign breast tumors
-
Kufe, D.; Inghirami, G.; Abe, M.; Hayes, D.; Justi-Wheeler, H.; Schlom, J. Differential reactivity of a novel monoclonal antibody (DF3) with human malignant versus benign breast tumors Hybridoma 1984, 3, 223-232
-
(1984)
Hybridoma
, vol.3
, pp. 223-232
-
-
Kufe, D.1
Inghirami, G.2
Abe, M.3
Hayes, D.4
Justi-Wheeler, H.5
Schlom, J.6
-
53
-
-
0026623301
-
Suppression of cellular aggregation by high levels of episialin
-
Ligtenberg, M. J.; Buijs, F.; Vos, H. L.; Hilkens, J. Suppression of cellular aggregation by high levels of episialin Cancer Res. 1992, 52, 2318-2324
-
(1992)
Cancer Res.
, vol.52
, pp. 2318-2324
-
-
Ligtenberg, M.J.1
Buijs, F.2
Vos, H.L.3
Hilkens, J.4
-
54
-
-
0024361527
-
Structural analysis of the DF3 human breast carcinoma-associated protein
-
Abe, M.; Kufe, D. Structural analysis of the DF3 human breast carcinoma-associated protein Cancer Res. 1989, 49, 2834-2839
-
(1989)
Cancer Res.
, vol.49
, pp. 2834-2839
-
-
Abe, M.1
Kufe, D.2
-
55
-
-
0021854591
-
Use of a murine monoclonal antibody for detection of circulating plasma DF3 antigen levels in breast cancer patients
-
Hayes, D. F.; Sekine, H.; Ohno, T.; Abe, M.; Keefe, K.; Kufe, D. W. Use of a murine monoclonal antibody for detection of circulating plasma DF3 antigen levels in breast cancer patients J. Clin. Invest. 1985, 75, 1671-1678
-
(1985)
J. Clin. Invest.
, vol.75
, pp. 1671-1678
-
-
Hayes, D.F.1
Sekine, H.2
Ohno, T.3
Abe, M.4
Keefe, K.5
Kufe, D.W.6
-
56
-
-
70450247207
-
Mucins in cancer: Function, prognosis and therapy
-
Kufe, D. W. Mucins in cancer: function, prognosis and therapy Nat. Rev. Cancer 2009, 9, 874-885
-
(2009)
Nat. Rev. Cancer
, vol.9
, pp. 874-885
-
-
Kufe, D.W.1
-
57
-
-
0033603547
-
Purification and characterization of a complex containing matriptase and a Kunitz-type serine protease inhibitor from human milk
-
Lin, C. Y.; Anders, J.; Johnson, M.; Dickson, R. B. Purification and characterization of a complex containing matriptase and a Kunitz-type serine protease inhibitor from human milk J. Biol. Chem. 1999, 274, 18237-18242
-
(1999)
J. Biol. Chem.
, vol.274
, pp. 18237-18242
-
-
Lin, C.Y.1
Anders, J.2
Johnson, M.3
Dickson, R.B.4
-
58
-
-
0030894268
-
Hepatocyte growth factor activator inhibitor, a novel Kunitz-type serine protease inhibitor
-
Shimomura, T.; Denda, K.; Kitamura, A.; Kawaguchi, T.; Kito, M.; Kondo, J.; Kagaya, S.; Qin, L.; Takata, H.; Miyazawa, K.; Kitamura, N. Hepatocyte growth factor activator inhibitor, a novel Kunitz-type serine protease inhibitor J. Biol. Chem. 1997, 272, 6370-6376
-
(1997)
J. Biol. Chem.
, vol.272
, pp. 6370-6376
-
-
Shimomura, T.1
Denda, K.2
Kitamura, A.3
Kawaguchi, T.4
Kito, M.5
Kondo, J.6
Kagaya, S.7
Qin, L.8
Takata, H.9
Miyazawa, K.10
Kitamura, N.11
-
59
-
-
0037134489
-
Functional characterization of Kunitz domains in hepatocyte growth factor activator inhibitor type 1
-
Denda, K.; Shimomura, T.; Kawaguchi, T.; Miyazawa, K.; Kitamura, N. Functional characterization of Kunitz domains in hepatocyte growth factor activator inhibitor type 1 J. Biol. Chem. 2002, 277, 14053-14059
-
(2002)
J. Biol. Chem.
, vol.277
, pp. 14053-14059
-
-
Denda, K.1
Shimomura, T.2
Kawaguchi, T.3
Miyazawa, K.4
Kitamura, N.5
-
60
-
-
0034704164
-
Hepatocyte growth factor activator inhibitor type 1 is a specific cell surface binding protein of hepatocyte growth factor activator (HGFA) and regulates HGFA activity in the pericellular microenvironment
-
Kataoka, H.; Shimomura, T.; Kawaguchi, T.; Hamasuna, R.; Itoh, H.; Kitamura, N.; Miyazawa, K.; Koono, M. Hepatocyte growth factor activator inhibitor type 1 is a specific cell surface binding protein of hepatocyte growth factor activator (HGFA) and regulates HGFA activity in the pericellular microenvironment J. Biol. Chem. 2000, 275, 40453-40462
-
(2000)
J. Biol. Chem.
, vol.275
, pp. 40453-40462
-
-
Kataoka, H.1
Shimomura, T.2
Kawaguchi, T.3
Hamasuna, R.4
Itoh, H.5
Kitamura, N.6
Miyazawa, K.7
Koono, M.8
-
61
-
-
84866237333
-
Loss of membrane-bound serine protease inhibitor HAI-1 induces oral squamous cell carcinoma cells' invasiveness
-
Baba, T.; Kawaguchi, M.; Fukushima, T.; Sato, Y.; Orikawa, H.; Yorita, K.; Tanaka, H.; Lin, C. Y.; Sakoda, S.; Kataoka, H. Loss of membrane-bound serine protease inhibitor HAI-1 induces oral squamous cell carcinoma cells' invasiveness J. Pathol. 2012, 228, 181-192
-
(2012)
J. Pathol.
, vol.228
, pp. 181-192
-
-
Baba, T.1
Kawaguchi, M.2
Fukushima, T.3
Sato, Y.4
Orikawa, H.5
Yorita, K.6
Tanaka, H.7
Lin, C.Y.8
Sakoda, S.9
Kataoka, H.10
-
62
-
-
84876915973
-
Hepatocyte growth factor activator inhibitor type 1 is a suppressor of intestinal tumorigenesis
-
Hoshiko, S.; Kawaguchi, M.; Fukushima, T.; Haruyama, Y.; Yorita, K.; Tanaka, H.; Seiki, M.; Inatsu, H.; Kitamura, K.; Kataoka, H. Hepatocyte growth factor activator inhibitor type 1 is a suppressor of intestinal tumorigenesis Cancer Res. 2013, 73, 2659-2670
-
(2013)
Cancer Res.
, vol.73
, pp. 2659-2670
-
-
Hoshiko, S.1
Kawaguchi, M.2
Fukushima, T.3
Haruyama, Y.4
Yorita, K.5
Tanaka, H.6
Seiki, M.7
Inatsu, H.8
Kitamura, K.9
Kataoka, H.10
-
63
-
-
33645339258
-
Serum hepatocyte growth factor activator inhibitor type i (HAI-I) and type 2 (HAI-2) in prostate cancer
-
Nagakawa, O.; Yamagishi, T.; Akashi, T.; Nagaike, K.; Fuse, H. Serum hepatocyte growth factor activator inhibitor type I (HAI-I) and type 2 (HAI-2) in prostate cancer Prostate 2006, 66, 447-452
-
(2006)
Prostate
, vol.66
, pp. 447-452
-
-
Nagakawa, O.1
Yamagishi, T.2
Akashi, T.3
Nagaike, K.4
Fuse, H.5
-
64
-
-
84878539640
-
Combined proteome and transcriptome analyses for the discovery of urinary biomarkers for urothelial carcinoma
-
Shimwell, N. J.; Bryan, R. T.; Wei, W.; James, N. D.; Cheng, K. K.; Zeegers, M. P.; Johnson, P. J.; Martin, A.; Ward, D. G. Combined proteome and transcriptome analyses for the discovery of urinary biomarkers for urothelial carcinoma Br. J. Cancer 2013, 108, 1854-1861
-
(2013)
Br. J. Cancer
, vol.108
, pp. 1854-1861
-
-
Shimwell, N.J.1
Bryan, R.T.2
Wei, W.3
James, N.D.4
Cheng, K.K.5
Zeegers, M.P.6
Johnson, P.J.7
Martin, A.8
Ward, D.G.9
-
65
-
-
0028800295
-
Thrombospondin-4, an extracellular matrix protein expressed in the developing and adult nervous system promotes neurite outgrowth
-
Arber, S.; Caroni, P. Thrombospondin-4, an extracellular matrix protein expressed in the developing and adult nervous system promotes neurite outgrowth J. Cell Biol. 1995, 131, 1083-1094
-
(1995)
J. Cell Biol.
, vol.131
, pp. 1083-1094
-
-
Arber, S.1
Caroni, P.2
-
66
-
-
0028833511
-
Characterization of human thrombospondin-4
-
Lawler, J.; McHenry, K.; Duquette, M.; Derick, L. Characterization of human thrombospondin-4 J. Biol. Chem. 1995, 270, 2809-2814
-
(1995)
J. Biol. Chem.
, vol.270
, pp. 2809-2814
-
-
Lawler, J.1
McHenry, K.2
Duquette, M.3
Derick, L.4
-
67
-
-
0034711305
-
Thrombospondin-4 binds specifically to both collagenous and non-collagenous extracellular matrix proteins via its C-terminal domains
-
Narouz-Ott, L.; Maurer, P.; Nitsche, D. P.; Smyth, N.; Paulsson, M. Thrombospondin-4 binds specifically to both collagenous and non-collagenous extracellular matrix proteins via its C-terminal domains J. Biol. Chem. 2000, 275, 37110-37117
-
(2000)
J. Biol. Chem.
, vol.275
, pp. 37110-37117
-
-
Narouz-Ott, L.1
Maurer, P.2
Nitsche, D.P.3
Smyth, N.4
Paulsson, M.5
-
68
-
-
84885674178
-
Thrombospondin-4 expression is activated during the stromal response to invasive breast cancer
-
Amy, E. M.; Song, S.; Kutasovic, J. R.; Reid, L. E.; Valle, J. M.; Vargas, A. C.; Smart, C. E.; Simpson, P. T. Thrombospondin-4 expression is activated during the stromal response to invasive breast cancer Virchows Arch. 2013, 463, 535-545
-
(2013)
Virchows Arch.
, vol.463
, pp. 535-545
-
-
Amy, E.M.1
Song, S.2
Kutasovic, J.R.3
Reid, L.E.4
Valle, J.M.5
Vargas, A.C.6
Smart, C.E.7
Simpson, P.T.8
-
69
-
-
80053562076
-
THBS4, a novel stromal molecule of diffuse-type gastric adenocarcinomas, identified by transcriptome-wide expression profiling
-
Forster, S.; Gretschel, S.; Jons, T.; Yashiro, M.; Kemmner, W. THBS4, a novel stromal molecule of diffuse-type gastric adenocarcinomas, identified by transcriptome-wide expression profiling Mod. Pathol. 2011, 24, 1390-1403
-
(2011)
Mod. Pathol.
, vol.24
, pp. 1390-1403
-
-
Forster, S.1
Gretschel, S.2
Jons, T.3
Yashiro, M.4
Kemmner, W.5
-
70
-
-
77956605948
-
Thrombospondin-4 is a putative tumour-suppressor gene in colorectal cancer that exhibits age-related methylation
-
Greco, S. A.; Chia, J.; Inglis, K. J.; Cozzi, S. J.; Ramsnes, I.; Buttenshaw, R. L.; Spring, K. J.; Boyle, G. M.; Worthley, D. L.; Leggett, B. A.; Whitehall, V. L. Thrombospondin-4 is a putative tumour-suppressor gene in colorectal cancer that exhibits age-related methylation BMC Cancer 2010, 494
-
(2010)
BMC Cancer
, pp. 494
-
-
Greco, S.A.1
Chia, J.2
Inglis, K.J.3
Cozzi, S.J.4
Ramsnes, I.5
Buttenshaw, R.L.6
Spring, K.J.7
Boyle, G.M.8
Worthley, D.L.9
Leggett, B.A.10
Whitehall, V.L.11
|